Page last updated: 2024-12-10

antheraxanthin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

antheraxanthin: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

antheraxanthin : An epoxycarotenol that is beta-carotene-3,3'-diol in which one of the one of the endocyclic double bonds has been oxidised to the corresponding epoxide. It is a neutral yellow plant pigment found in Euglenophyta. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5281223
CHEBI ID27867
SCHEMBL ID96300
MeSH IDM0098052

Synonyms (29)

Synonym
BSPBIO_003502
SPECTRUM5_000366
LMPR01070262
antheraxanthin
640-03-9
C08579 ,
NCGC00178026-01
CHEBI:27867 ,
5,6-epoxy-5,6-dihydro-beta,beta-carotene-3,3'-diol
(3r,3's,5'r,6's)-5',6'-dihydro-5',6'-epoxy-beta,beta-carotene-3,3'-diol
all-trans-antheraxanthin
(1r,3s,6s)-6-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol
unii-0306j2l3dv
0306j2l3dv ,
beta,beta-carotene-3,3'-diol, 5,6-epoxy-5,6-dihydro- (van)
CCG-38889
SCHEMBL96300
(1r,3s,6s)-6-((1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-((4r)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl)-1,5,5-trimethyl-7-oxabicyclo(4.1.0)heptan-3-ol
all-trans-antheraxanthin a
.beta.,.beta.-carotene-3,3'-diol, 5,6-epoxy-5,6-dihydro-, (3s,3'r,5r,6s)-
(1r,3s,6s)-6-((1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-((r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl)-1,5,5-trimethyl-7-oxabicyclo(4.1.0)heptan-3-ol
trans-antheraxanthin
.beta.-carotene-3,3'-diol, 5,6-epoxy-5,6-dihydro-
(3r,3's,5'r,6's)-5',6' -dihydro-5',6'-epoxy-.beta.,.beta.-carotene-3,3'-diol
5,6-epoxy-5,6-dihydro-.beta.,.beta.-carotene-3,3'-diol
.beta.-carotene-3,3'-diol, 5,6-epoxy-5,6-dihydro-, all-trans-
25494-44-4
Q572404
DTXSID601015587
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
biological pigmentAn endogenous molecular entity that results in a colour of an organism as the consequence of the selective absorption of light.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
epoxycarotenol
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
superpathway of carotenoid biosynthesis in plants431
violaxanthin, antheraxanthin and zeaxanthin interconversion59
capsanthin and capsorubin biosynthesis27
violaxanthin, antheraxanthin and zeaxanthin interconversion99
superpathway of carotenoid biosynthesis in plants2432
Carotenoid biosynthesis012
Carotenoid biosynthesis525

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (60)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (5.00)18.7374
1990's4 (6.67)18.2507
2000's24 (40.00)29.6817
2010's26 (43.33)24.3611
2020's3 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.63 (24.57)
Research Supply Index4.13 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.64%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (98.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]